Log In
Print this Print this

Iprivask, Revasc, desirudin

  Manage Alerts
Collapse Summary General Information
Company Canyon Pharmaceuticals AG
DescriptionRecombinant direct thrombin inhibitor (DTI)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today